- SBI Life’s net income for the fourth quarter was 8.14 billion rupees, showing a slight year-over-year increase of 0.3%.
- The net income fell below the estimate of 10.38 billion rupees.
- Net premium income was reported at 238.6 billion rupees, reflecting a 5% decline compared to the previous year.
- This net premium income was lower than the estimated 248.95 billion rupees.
- The current market consensus for SBI Life includes 32 buy ratings, 4 hold ratings, and no sell ratings.
A look at SBI Life Insurance Co Ltd Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 2 | |
| Growth | 4 | |
| Resilience | 4 | |
| Momentum | 5 | |
| OVERALL SMART SCORE | 3.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on the Smartkarma Smart Scores for SBI Life Insurance Co Ltd, the company has a positive long-term outlook. With strong momentum and growth scores of 5 and 4 respectively, SBI Life Insurance is positioned well for future expansion and market performance. This indicates that the company is likely to experience continued growth in the coming years.
Additionally, SBI Life Insurance Co Ltd has shown resilience in its operations, which suggests that it can weather economic uncertainties and market fluctuations. While the value and dividend scores are moderate at 2, the overall Smartkarma Smart Scores paint a promising picture for the company, indicating a solid foundation for sustained success in the competitive insurance industry.
Summary: SBI Life Insurance Company Limited, offering a range of financial services including claims, general insurance, online banking, retirement plans, tax calculators, and more, is well-positioned for long-term growth and resilience in serving its customer base in India.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
